Rejoinder: Improving precision and power in randomized trials for COVID-19 treatments using covariate adjustment, for binary, ordinal, and time-to-event outcomes

Bibliographic Details
Main Authors:	Benkeser, D. (Author), Díaz, I. (Author), Luedtke, A. (Author), Rosenblum, M. (Author), Scharfstein, D. (Author), Segal, J. (Author)
Format:	Article
Language:	English
Published:	John Wiley and Sons Inc 2021
Subjects:	biology COVID-19 Data Interpretation, Statistical disease control drug drug therapy health risk human Humans randomized controlled trial (topic) Randomized Controlled Trials as Topic SARS-CoV-2 statistical analysis
Online Access:	View Fulltext in Publisher

View Fulltext in Publisher

Similar Items